English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Nifedipine and FPL 64176 (FPL), which block and potentiate L-type voltage-gated Ca 2+ channels, respectively, modulate Ca v 1.2 more potently than Ca v 1.3. To identify potential strategies for developing subtype-selective inhibitors, we investigated the role of divergent amino acid residues in transmembrane domains IIIS5 and the extracellular IIIS5-3P loop region in modulation of these channels by nifedipine and FPL. Insertion of the extracellular IIIS5-3P loop from Ca v 1.2 into Ca v 1.3 (Ca v 1.3+) reduced the IC 50 of nifedipine from 289 to 101 nM, and substitution of S1100 with an A residue, as in Ca v 1.2, accounted for this difference. Substituting M1030 in IIIS5 to V in Ca v 1.3+ (Ca v 1.3+V) further reduced the IC 50 of nifedipine to 42 nM. FPL increased current amplitude with an EC 50 of 854 nM in Ca v 1.3, 103 nM in Ca v 1.2, and 99 nM in Ca v 1.3+V. In contrast to nifedipine block, substitution of M1030 to V in Ca v 1.3 had no effect on potency of FPL potentiation of current amplitude, but slowed deactivation in the presence and absence of 10 μ M FPL. FPL had no effect on deactivation of Ca v 1.3/dihydropyridine-insensitive (DHPi), a channel with very low sensitivity to nifedipine block (IC 50 ∼93 μ M), but did shift the voltage-dependence of activation by ∼-10 mV. We conclude that the M/V variation in IIIS5 and the S/A variation in the IIIS5-3P loop of Ca v 1.2 and Ca v 1.3 largely determine the difference in nifedipine potency between these two channels, but the difference in FPL potency is determined by divergent amino acids in the IIIS5-3P loop.

Molecular Determinants of the Differential Modulation of Cav1.2 and Cav1.3 by Nifedipine and FPL 64176

Molecular Determinants of the Differential Modulation of Ca_v1.2 and Ca_v1.3 by Nifedipine and FPL 64176